WHITNEY SIMMONS: Open Payments
NPI 1679180699 · OKLAHOMA CITY, OK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$22,829 in 61 payments from 10 companies in 2025. Trend: 2023 $3,124 · 2024 $11,912 · 2025 $22,829
Travel & lodging: $6,389Consulting: $5,405Speaker / faculty: $5,380Speaker / faculty: $4,500Food & beverage: $1,155
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | 26 | $14,180 |
| Eisai Inc. | 24 | $8,267 |
| EMD Serono, Inc. | 1 | $106 |
| Biogen, Inc. | 1 | $60 |
| Lundbeck LLC | 3 | $54 |
| Genentech USA, Inc. | 2 | $51 |
| TerSera Therapeutics LLC | 1 | $33 |
| ABBVIE INC. | 1 | $27 |
| CONMED Corporation | 1 | $27 |
| Alexion Pharmaceuticals, Inc. | 1 | $23 |
Products named: Leqembi, HYQVIA, TYSABRI, VYEPTI, Ocrevus Zunovo, Quzyttir, SKYRIZI, AIRSEAL.
Industry payments across OK — which companies pay providers there.
